Cell & Gene Therapy
Stem Cell Science & Regenerative Medicines
Cell and Gene therapies are life-changing new categories of medicines whose full potential is only just beginning to emerge. They are cutting-edge and rapidly progressing fields of Biological Therapies. Both therapies aim to
treat, prevent or potentially cure diseases and both approaches offer the potential to diminish the fundamental cause of genetic and acquired diseases by substituting the missing protein or cells causing the disease’s symptoms. Cell and gene therapies may offer longer lasting effects than traditional medicines. They are overlapping fields of biomedical research and treatments. However, cell and gene therapies work differently. Cell therapy aims to treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body while gene therapy treats diseases by replacing, inactivating or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo). Some therapies are considered both cell and gene therapies. These therapies work by modifying genes in specific types of cells and inserting them into the body.
With the promising significance of Cell and Gene therapy, it is poised to transform the healthcare and biopharma industry soon. The market is estimated to increase expeditiously, encompassing sales forecasts of
EUR 27.9 billion by 2026. The development of biological therapies is rapidly expanding, however, it poses different challenges to research and development, authorisation, manufacturing, accessibility, and ensuring safety throughout the lifecycle of the product.
The two-day Congress will provide an interactive, cutting edge, and comprehensive discussions in collaborative format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies, and concepts to help you gain access to the booming CGT market.
We are putting together an agenda that focuses on “Realising the promises of next generation therapies”.
We are gathering high calibre expert speakers to participate and share their knowledge and expertise through Keynote Presentations and Panel discussions, addressing all aspects of the industry.
We look forward to welcoming you to the CGT World Congress 2022!
GAIN LATEST INSIGHTS ON:
• Clinical Research Organizations
• Research and Development
• Personalised Medicine
• Regenerative Medicine
• External R&D Innovation
• Innovative Medicine
• Rare and Ultra-Rare Diseases
• Cell and Gene Therapy
• Translational Science
• Molecular Geneticist
• Program Management
• Patient and Patient Groups
• Public Affairs
• Medical Affairs
• Regulatory Affairs
• Market Access
• Pricing and Reimbursement
• Health Economics Outcomes Research
• Commercial Development
• Investments and Funding
• Product Specialist
• Global Strategic Services
• Business Planning and Operations
Stem cell research, tissue engineering, and regenerative medicine hold the potential to revolutionize the way human diseases are treated, and many nations have therefore invested heavily in these genetically engineered components and its applications. Considerable research has enabled the fabrication of sophisticated grafts and cell manipulation technologies to analyze the molecular level of controlling cell behavior and repairing tissue. However, these revolutionary medicines are also controversial with many ethical and regulatory questions that impact a nation’s policies.
The upcoming 2022 Stem Cell Science and Regenerative Medicines Congress focuses on a diverse range of topics and addresses the challenges, obstacles, and opportunities for innovation in the design and execution of clinical trials.
This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory, and many more.
We look forward to welcoming you to the SCS & RM World Congress 2022!
Gain insights on:
Who Should Attend
Network with scientists, analysts, senior VPs, Heads, Directors, and Managers of leading biopharmaceutical, biotech companies, Governments agencies, and Academia, whose responsibilities includes:
KEYNOTE PANEL DISCUSSION
KEYNOTE PANEL DISCUSSION
Process parameters for the high-scale production alginate-encapsulated stem cells for storage and distribution throughout the cell therapy supply chain
No Spam - You will only receive relevant information on Cell & Gene Therapy and Stem Cell & Regenerative Medicines, and events updates.
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.